GenomeScan is partnering with Olink Proteomics to bring proteomics to the next level by enabling high-throughput analysis of thousands of proteins, while using less than a drop of blood.
Olink’s PEA technology that is based on dual antibody recognition results in the coupling of DNA oligonucleotides and boasts exceptional levels of specificity, sensitivity and dynamic range.
By combining different omics approaches, GenomeScan helps facilitates researchers in identifying the regulators of biological processes, identifying new targets for drug discovery, evaluating therapeutic interventions, and identifying biomarkers that can be used for diagnosis, prognosis, and disease monitoring, leading to more precise and effective treatments.
20 November 2025, The winner of the Venture Challenge Fall 2025 was announced at the Dutch Life Sciences Conference. We are proud to share that Myriagon has been selected as this...
The Leiden University Medical Center (LUMC) and KickstartAI are taking an important step today toward reducing administrative tasks in healthcare. They are starting the...
Leiden, 14 November – Today, on World Diabetes Day, the new Cure One research center was officially opened by Peter Heijkoop, the mayor of Leiden. Cure One is an initiative of...